Tablets
Haematological malignancies
Acala TECH
Acalabrutinib Tablets
Product pack shot.
A second-generation BTK inhibitor for chronic lymphocytic leukaemia and mantle cell lymphoma, taken twice daily for as long as it keeps working.
100 mg
| Brand | Acala TECH |
|---|---|
| Composition | Acalabrutinib Tablets |
| Dosage form | Film-coated tablets |
| Strengths | 100 mg |
| Presentation | Blister of 60 tablets |
| Therapeutic area | Haematological malignancies |
| Category | Prescription only (Rx) |
Product information
About Acalabrutinib
- Selective Bruton tyrosine kinase (BTK) inhibitor.
- Indicated in CLL / SLL and relapsed or refractory mantle cell lymphoma.
- Usual dose 100 mg approximately every 12 hours, with or without food.
- Store below 30 °C in the original pack.
Related products
